Cargando…
Long-term nitrofurantoin: an analysis of complication awareness, monitoring, and pulmonary injury cases
BACKGROUND: Long-term nitrofurantoin (NF) treatment can result in pulmonary and hepatic injury. Current guidelines do not outline the type or frequency of monitoring required for detection of these injuries. AIM: To assess 1) awareness of NF complications among prescribers; 2) monitoring practice; a...
Autores principales: | , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Royal College of General Practitioners
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9447296/ https://www.ncbi.nlm.nih.gov/pubmed/34407964 http://dx.doi.org/10.3399/BJGPO.2021.0083 |
_version_ | 1784783826000543744 |
---|---|
author | Speirs, Toby Peter Tuffin, Nicole Mundy-Baird, Finlay Sakota, Helena Mulholland, Sarah Westlake, Michelle Lyon, Max Medford, Andrew R Sharp, Charles Darby, Michael Albur, Mahableshwar Keeley, Francis Burden, Helena Kenward, Charlie Jonas, Elizabeth Barratt, Shaney Adamali, Huzaifa I |
author_facet | Speirs, Toby Peter Tuffin, Nicole Mundy-Baird, Finlay Sakota, Helena Mulholland, Sarah Westlake, Michelle Lyon, Max Medford, Andrew R Sharp, Charles Darby, Michael Albur, Mahableshwar Keeley, Francis Burden, Helena Kenward, Charlie Jonas, Elizabeth Barratt, Shaney Adamali, Huzaifa I |
author_sort | Speirs, Toby Peter |
collection | PubMed |
description | BACKGROUND: Long-term nitrofurantoin (NF) treatment can result in pulmonary and hepatic injury. Current guidelines do not outline the type or frequency of monitoring required for detection of these injuries. AIM: To assess 1) awareness of NF complications among prescribers; 2) monitoring practice; and 3) to describe the pulmonary sequelae of NF-related complications. DESIGN & SETTING: Evaluation of prescribing habits by questionnaires and review of GP databases, and case-note review in secondary care. METHOD: The following study procedures were undertaken: 1) an electronic questionnaire was distributed to prescribers, interrogating prescribing and monitoring practices, and awareness of complications; 2) an analysis was undertaken (June–July 2020) of NF monitoring among GPs in the local clinical commissioning group (CCG); and 3) a case review was carried out of patients diagnosed with NF-induced interstitial lung disease (NFILD) at the interstitial lung disease (ILD) centre (2014–2020). RESULTS: A total of 125 prescribers of long-term NF responded to the questionnaire (82.4% GPs; 12.0% urologists). Many were unaware of the potential for liver (42.4%) and lung (28.0%) complications; 40.8% and 52.8% never monitored for these, respectively. Only 53.3% of urologists believed themselves responsible for arranging monitoring, while nearly all GPs believed this to be the prescriber’s responsibility (94.2%). One-third of all responders considered current British National Formulary (BNF) guidelines 'not at all sufficient/clear', with mean clarity scoring of 2.2/5. Among patients with NFILD (n = 46), NF had been prescribed most often (69.6%) for treatment of recurrent UTI and 58.6% (n = 27) were prescribed for >6 months. On withdrawal of the medication 61.4% displayed resolution (completely or minimal fibrosis), while 15.9% of patients had progressive lung fibrosis. CONCLUSION: NF can cause marked or irreversible lung complications and there is currently a shortfall in awareness and monitoring. Existing monitoring guidelines should be augmented. |
format | Online Article Text |
id | pubmed-9447296 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Royal College of General Practitioners |
record_format | MEDLINE/PubMed |
spelling | pubmed-94472962022-09-07 Long-term nitrofurantoin: an analysis of complication awareness, monitoring, and pulmonary injury cases Speirs, Toby Peter Tuffin, Nicole Mundy-Baird, Finlay Sakota, Helena Mulholland, Sarah Westlake, Michelle Lyon, Max Medford, Andrew R Sharp, Charles Darby, Michael Albur, Mahableshwar Keeley, Francis Burden, Helena Kenward, Charlie Jonas, Elizabeth Barratt, Shaney Adamali, Huzaifa I BJGP Open Research BACKGROUND: Long-term nitrofurantoin (NF) treatment can result in pulmonary and hepatic injury. Current guidelines do not outline the type or frequency of monitoring required for detection of these injuries. AIM: To assess 1) awareness of NF complications among prescribers; 2) monitoring practice; and 3) to describe the pulmonary sequelae of NF-related complications. DESIGN & SETTING: Evaluation of prescribing habits by questionnaires and review of GP databases, and case-note review in secondary care. METHOD: The following study procedures were undertaken: 1) an electronic questionnaire was distributed to prescribers, interrogating prescribing and monitoring practices, and awareness of complications; 2) an analysis was undertaken (June–July 2020) of NF monitoring among GPs in the local clinical commissioning group (CCG); and 3) a case review was carried out of patients diagnosed with NF-induced interstitial lung disease (NFILD) at the interstitial lung disease (ILD) centre (2014–2020). RESULTS: A total of 125 prescribers of long-term NF responded to the questionnaire (82.4% GPs; 12.0% urologists). Many were unaware of the potential for liver (42.4%) and lung (28.0%) complications; 40.8% and 52.8% never monitored for these, respectively. Only 53.3% of urologists believed themselves responsible for arranging monitoring, while nearly all GPs believed this to be the prescriber’s responsibility (94.2%). One-third of all responders considered current British National Formulary (BNF) guidelines 'not at all sufficient/clear', with mean clarity scoring of 2.2/5. Among patients with NFILD (n = 46), NF had been prescribed most often (69.6%) for treatment of recurrent UTI and 58.6% (n = 27) were prescribed for >6 months. On withdrawal of the medication 61.4% displayed resolution (completely or minimal fibrosis), while 15.9% of patients had progressive lung fibrosis. CONCLUSION: NF can cause marked or irreversible lung complications and there is currently a shortfall in awareness and monitoring. Existing monitoring guidelines should be augmented. Royal College of General Practitioners 2021-10-27 /pmc/articles/PMC9447296/ /pubmed/34407964 http://dx.doi.org/10.3399/BJGPO.2021.0083 Text en Copyright © 2021, The Authors https://creativecommons.org/licenses/by/4.0/This article is Open Access: CC BY license (https://creativecommons.org/licenses/by/4.0/) |
spellingShingle | Research Speirs, Toby Peter Tuffin, Nicole Mundy-Baird, Finlay Sakota, Helena Mulholland, Sarah Westlake, Michelle Lyon, Max Medford, Andrew R Sharp, Charles Darby, Michael Albur, Mahableshwar Keeley, Francis Burden, Helena Kenward, Charlie Jonas, Elizabeth Barratt, Shaney Adamali, Huzaifa I Long-term nitrofurantoin: an analysis of complication awareness, monitoring, and pulmonary injury cases |
title | Long-term nitrofurantoin: an analysis of complication awareness, monitoring, and pulmonary injury cases |
title_full | Long-term nitrofurantoin: an analysis of complication awareness, monitoring, and pulmonary injury cases |
title_fullStr | Long-term nitrofurantoin: an analysis of complication awareness, monitoring, and pulmonary injury cases |
title_full_unstemmed | Long-term nitrofurantoin: an analysis of complication awareness, monitoring, and pulmonary injury cases |
title_short | Long-term nitrofurantoin: an analysis of complication awareness, monitoring, and pulmonary injury cases |
title_sort | long-term nitrofurantoin: an analysis of complication awareness, monitoring, and pulmonary injury cases |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9447296/ https://www.ncbi.nlm.nih.gov/pubmed/34407964 http://dx.doi.org/10.3399/BJGPO.2021.0083 |
work_keys_str_mv | AT speirstobypeter longtermnitrofurantoinananalysisofcomplicationawarenessmonitoringandpulmonaryinjurycases AT tuffinnicole longtermnitrofurantoinananalysisofcomplicationawarenessmonitoringandpulmonaryinjurycases AT mundybairdfinlay longtermnitrofurantoinananalysisofcomplicationawarenessmonitoringandpulmonaryinjurycases AT sakotahelena longtermnitrofurantoinananalysisofcomplicationawarenessmonitoringandpulmonaryinjurycases AT mulhollandsarah longtermnitrofurantoinananalysisofcomplicationawarenessmonitoringandpulmonaryinjurycases AT westlakemichelle longtermnitrofurantoinananalysisofcomplicationawarenessmonitoringandpulmonaryinjurycases AT lyonmax longtermnitrofurantoinananalysisofcomplicationawarenessmonitoringandpulmonaryinjurycases AT medfordandrewr longtermnitrofurantoinananalysisofcomplicationawarenessmonitoringandpulmonaryinjurycases AT sharpcharles longtermnitrofurantoinananalysisofcomplicationawarenessmonitoringandpulmonaryinjurycases AT darbymichael longtermnitrofurantoinananalysisofcomplicationawarenessmonitoringandpulmonaryinjurycases AT alburmahableshwar longtermnitrofurantoinananalysisofcomplicationawarenessmonitoringandpulmonaryinjurycases AT keeleyfrancis longtermnitrofurantoinananalysisofcomplicationawarenessmonitoringandpulmonaryinjurycases AT burdenhelena longtermnitrofurantoinananalysisofcomplicationawarenessmonitoringandpulmonaryinjurycases AT kenwardcharlie longtermnitrofurantoinananalysisofcomplicationawarenessmonitoringandpulmonaryinjurycases AT jonaselizabeth longtermnitrofurantoinananalysisofcomplicationawarenessmonitoringandpulmonaryinjurycases AT barrattshaney longtermnitrofurantoinananalysisofcomplicationawarenessmonitoringandpulmonaryinjurycases AT adamalihuzaifai longtermnitrofurantoinananalysisofcomplicationawarenessmonitoringandpulmonaryinjurycases |